PMID: 12767845May 28, 2003Paper

Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital

The Journal of Hospital Infection
Melek AyanBengul Durmaz

Abstract

Over an 18 month period, the bacteriological, clinical and epidemiological characteristics of nosocomial Acinetobacter baumannii infections in a teaching hospital were studied. Typing studies were performed on 38 strains isolated from 36 patients. Twenty-two of the strains were isolated during the three outbreaks. Surgery, catheterization, mechanical ventilation, and antibiotic therapy for adult patients and respiratory distress syndrome, mechanical ventilation, and prematurity for paediatric patients were the main risk factors identified. All isolates were resistant to penicillins (except ampicillin-sulbactam), cephalosporins, gentamicin, and aztreonam but susceptible to carbapenems and colistin. Resistance to tobramycin, ciprofloxacin, ampicillin-sulbactam, trimethoprim-sulfamethoxazole, and amikacin was variable. Antibiotyping, arbitrarily-primed polymerase chain reaction (AP-PCR) and the pulse-field gel electrophoresis (PFGE) indicated the epidemiological relationship. The outbreak strains, demonstrated genetic distinction between our three outbreaks and isolates from specific areas in the hospital.

References

Oct 1, 1993·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·R V Goering
Jul 17, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C A WebsterK J Towner
Feb 28, 2001·Seminars in Respiratory Infections·J Chastre, J L Trouillet
Apr 4, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G BouJ Martínez-Beltrán
May 25, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Andrew E SimorMarie Louie
Nov 26, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J M Cisneros, J Rodríguez-Baño

❮ Previous
Next ❯

Citations

Sep 15, 2004·Journal of Clinical Microbiology·Noriyuki NaganoYoshichika Arakawa
Oct 8, 2005·American Journal of Respiratory and Critical Care Medicine·Sylvia KnappTom van der Poll
Feb 12, 2005·Emerging Infectious Diseases·Aharon AbboYehuda Carmeli
Jan 27, 2006·Antimicrobial Agents and Chemotherapy·Juliana CoelhoDavid Livermore
Aug 30, 2005·Scandinavian Journal of Infectious Diseases·Hsin-Pai ChenCheng-Yi Liu
Feb 24, 2015·Current Medical Research and Opinion·Abed Zahedi Bialvaei, Hossein Samadi Kafil
Nov 22, 2008·The Lancet Infectious Diseases·Drosos E Karageorgopoulos, Matthew E Falagas
Jun 16, 2007·The Journal of Infection·Jesús OteoUNKNOWN Red Española de Investigación en Patología Infecciosa
Oct 4, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Marie KempfDidier Raoult
Nov 26, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Eric J McGrathKeith S Kaye
May 20, 2006·Scandinavian Journal of Infectious Diseases·Emine AlpMehmet Doganay
Jan 15, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sofiane BakourJean-Marc Rolain
Feb 24, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Melda SinirtaşSuna Gedikoğlu
Feb 21, 2009·Journal of Translational Medicine·Hossam M Ashour, Amany El-Sharif
Apr 18, 2013·Asian Pacific Journal of Tropical Biomedicine·Reza MirnejadFaramaz Masjedian
Oct 8, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Titus L DanielsThomas R Talbot
Apr 20, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Halis AkalinSuna Gedikoglu
Jul 11, 2008·The Annals of Pharmacotherapy·Jason C Gallagher, Heather M Rouse
May 24, 2013·Japanese Journal of Infectious Diseases·Aysegul Copur CicekRiza Durmaz
Jul 5, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Stefanos GiannakisCesar Pulgarin
Apr 10, 2013·Expert Review of Anti-infective Therapy·Jason M PogueKeith S Kaye
Aug 17, 2005·Emerging Infectious Diseases·Kepler A DavisPaula J Gray
Dec 14, 2019·Acta Microbiologica Et Immunologica Hungarica·Pakhshan A Hassan, Adel K Khider

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Melek AyanZeynep Cizmeci
Archives of Pediatrics & Adolescent Medicine
M E PichicheroA Sorrento
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Edward F KeenClinton K Murray
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
M L LingG C Wang
© 2022 Meta ULC. All rights reserved